SEC Tracker
Get the app

Possible new Cerenome shares

CNSYDilution

Known so far: no new shares from the prospectus covers read · shelf room about $10.6M · not yet read: converts, ATM.

Shelf room

  • Room today about $10.6M
  • One third of float $10.6M ($31.9M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $10.6M on the S-3 of Jun 5, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $31.9M public float stated as of Jun 30, 2025, $10.6M, nothing sold off it in the last 12 months. Sources: S-3/A Jun 5, 2026, effective Jun 5, 2026 · public float, as of Jun 30, 2025.

What could become new Cerenome (CNSY) shares: warrants and options and RSUs, each with the 10-Q, 10-K, S-3 or 424B filing it comes from.

Cerenome dilution ladder

Every source of new shares on record, from the filings that created it.

7.6M outstanding; up to 27.4M fully diluted, +262%

  1. Outstandingas of Aug 5, 2026 (10-Q filed Aug 14) · share count on the cover page
    7.6M
  2. Warrants5.8M10-Q Oct 30, 2025 · equity note
    +5.8M
  3. Options and RSUs11.3M options, 2.8M RSUs10-Q Oct 30, 2025 · equity note
    +14.1M

Not stated in the filings we read: an ATM program, convertible notes.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Financing terms to know

None found in filings since Oct 30, 2025.

Each term is quoted from the exhibit it comes from; numbers are as stated in the filing. A flag describes a financing term. It is not investment advice.

Shares outstanding

7.6M

Nov 2024 to Aug 2026: from 236K to 7.6M. Adjusted for the 1-for-25 reverse split by May 13, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.